Predictive factors of trans-arterial chemoembolization (tace) efficacy for hepatocellular carcinoma in arterial phase computed tomographic scan by Mohamed , Dahlia
  
PREDICTIVE FACTORS OF TRANS-ARTERIAL 
CHEMOEMBOLIZATION (TACE) EFFICACY FOR 
HEPATOCELLULAR CARCINOMA IN ARTERIAL PHASE 
COMPUTED TOMOGRAPHIC SCAN. 
 
By: 
 
DR DAHLIA BINTI MOHAMED 
 
 
Dissertation Submitted in Partial Fulfillment of the Requirements for 
Master of Medicine (Radiology) 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
2017 
i 
  
ACKNOWLEDGEMENT 
 
The completion of this undertaking could not have been possible without the participation 
and assistance of so many people whose names may not all be enumerated. Their 
contributions are sincerely appreciated and gratefully acknowledged. 
 
However, I would like to express deep appreciation and indebtness particularly to the 
following: 
1. Prof Madya Dr Mohd Shafie Abdullah and Dr Shafie Baba, lecturer/radiologist and 
supervisor of this dissertation. 
2. Dr Rizal Roslan, radiologist from Hospital Selayang who is also the co investigator of 
this study. 
3. Prof Madya Dr Mohd Ezane Aziz, Dr Win Mar @ Salmah, Dr Juhara Haron, Dr 
Norzila Abu Bakar, Dr Khairil Amir Sayuti, Dr Chandran, Dr Ahmad Tarmizi, Dr 
Wan Airene, Dr Ahmad Hadif and Prof Madya Dr Wan Ahmad Kamil, 
lecturers/radiologists all of whom directly or indirectly contributed their ideas and 
comments to the success of this study. 
4. Professor Dr Syed Hatim Noor and Kinny Wong for their help in biostatistics.  
5. Colleagues and all the staff in the Department of Radiology, HUSM. 
 
 
 
 
 
ii 
  
TABLE OF CONTENT 
  PAGE 
TITLE                                                                                                                             i 
ACKNOWLEDGEMENT                                                                                                ii 
TABLE OF CONTENTS                                                                                                iii 
LIST OF TABLE                                   v 
LIST OF FIGURES                     vi 
LIST OF ABBREVIATION                   vii 
ABSTRAK (BAHASA MALAYSIA)                viii 
ABSTRACT (ENGLISH)                     x 
 
CHAPTER 1: INTRODUCTION & LITERATURE REVIEW 
1.1 Introduction & Literature Review                             2 
 
CHAPTER 2: OBJECTIVES OF THE STUDY 
2.1                   General Objectives                              5 
2.2                   Specific Objectives                              5 
 
CHAPTER 3: MANUSCRIPT 
3.1                  Title page                    7 
3.2                  Abstract                    8 
3.3                  Introduction                             10 
3.4                  Methodology                             12 
 
iii 
  
3.5                 Results                               15 
3.6                 Discussion                   18 
3.7                 Conclusion                                20 
3.8           References                    21 
3.9                 Table and Figures                             23 
 
CHAPTER 4: GUIDELINE OF SELECTED JOURNAL 
4.0                 Guidelines/Instruction to Authors of selected journal                                   30 
 
CHAPTER 5: STUDY PROTOCOL 
5.1                    Study protocol                   35 
5.2                    Ethical approval letter                 45 
 
CHAPTER 6: APPENDICES 
6.1 Data Collection Sheet                  55 
 
 
 
 
 
 
 
 
 
iv 
  
LIST OF TABLES 
Table  Page 
1 Demographic data  
 
 
23 
2 Demographic data of study subjects according to different types of 
hepatitis infection 
 
 
24 
3 Association between tumour attenuation and tumour size and tumor 
response to TACE  
 
 
25 
4 
 
 
 
5 
 
 
 
6 
Association between tumour site and tumour response to TACE  
 
 
Univariate regression analysis on predictive factors associated with 
tumour response to TACE 
 
 
Multivariate regression analysis on predictive factors associated with 
tumour response to TACE 
26 
 
 
 
27 
 
 
 
28 
 
 
 
 
 
 
 
 
 
 
 
 
v 
  
LIST OF FIGURES 
 
Figure   
 
 Page 
1a                      Tumour volume in Pre TACE CT scan in arterial phase                  29       
 
1b                      Tumour volume in post TACE CT scan in arterial phase                   29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
  
LIST OF ABBREVIATIONS 
 
TACE Transarterial chemoembolization 
HCC Hepatocellular carcinoma 
HU Hounsefield Unit 
HUSM Hospital Universiti Sains Malaysia. 
AP 
WT 
PACS 
CT 
ROI 
 
 
 
 
 
 
Anterior-posterior diameter 
Width 
Picture archiving and communication system 
Computed Tomography 
Region of interest 
 
 
 
 
 
 
 
vii 
  
ABSTRAK  
Objektif: Tujuan kajian ini adalah (1) menganalisa faktor demografi pesakit yang 
didiagnosis dengan ketumbuhan hati yang menjalani prosedur TACE (2) mengenalpasti 
hubungan antara faktor ramalan (atenuasi, saiz dan lokasi ketumbuhan) dan tindakbalas 
ketumbuhan (isipadu baki ketumbuhan) kepada prosedur TACE (3) menentukan faktor 
ramalan yang menyumbang kepada tindak balas paling berkesan kepada prosedur TACE. 
Metodologi: Pesakit yang didiagnosis dengan ketumbuhan hati yang menjalani prosedur 
TACE menggunakan ‘drug eluting microparticles’ di Jabatan Radiologi Hospital USM dan 
Hospital Selayang dikenalpasti. Imej CT scan 144 ketumbuhan sebelum dan selepas 
procedure TACE dianalisis berdasarkan beberapa parameter (atenuasi, saiz dan lokasi). 
Tindak balas ketumbuhan terhadap prosedur TACE dinilai berdasarkan pengurangan saiz 
ketumbuhan.  
Keputusan: 144 ketumbuhan telah dianalisa dari CT scan dalam fasa arteri (arterial phase) 
sebelum dan selepas prosedur TACE. Analisis menggunakan ‘simple linear regression’ 
menunjukkan atenuasi dan saiz memberi hubungan yang signifikan dengan tindakbalas 
terhadap prosedur TACE (P<0.001). Tiada hubungan yang signifikan di antara lokasi 
ketumbuhan [ditengah atau ditepi (P=0.453) dan lobar kanan atau lobar kiri (P=0.705)] 
dengan tindakbalas terhadap prosedur TACE. Dari kedua-dua parameter yang signifikan, 
kami telah mendapati bahawa faktor ramalan yang paling berkesan terhadap prosedur TACE 
berdasarkan analisa ‘multiple linear regression’ adalah saiz ketumbuhan.  
Kesimpulan: Saiz ketumbuhan yang kecil dan Hounsefield unit yang tinggi adalah faktor 
ramalan yang signifikan terhadap tindakbalas berkesan kepada prosedur TACE. Lokasi   
ketumbuhan tidak memberi hubungan yang signifikan terhadap tindakbalas yang baik kepada 
prosedur TACE secara statistik.  
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Kata kunci: Ketumbuhan hati, TACE, CT scan dalam fasa arteri, Hounsefield unit, drug 
eluting microparticles. 
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ABSTRACT 
Objective: The aim of this study was (1) to evaluate demographic factors of patient with 
hepatocellular carcinoma who underwent TACE procedure (2) to identify the correlation 
between predictive factors (tumour attenuation, size and site of tumour) and response of 
tumour (volume of residual viable tumour) to TACE procedure (3) to determine which 
predictive factor contribute more to better tumor response to TACE. 
Methodology: Patients diagnosed with Hepatocellular carcinoma who underwent TACE 
procedure using drug eluting microparticles as the embolized material recruited from PACS 
system at Radiology Department Hospital USM and Hospital Selayang. CT findings (pre and 
post TACE) of 144 tumors were analysed using several parameters (attenuation, size and site 
of tumour). Response of tumour to TACE was assessed based on reduction of size of tumour 
volume.  
Results: A total of 144 nodules of HCC were analysed from pre- and post-TACE CT scan in 
arterial phase. Simple linear regression analysis revealed that tumour attenuation and size 
have significant association with the tumour response to TACE (P<0.001). There were no 
significant association found between the site of tumour [central or peripheral (p=0.453) and 
right lobe or left lobe (P=0.705)] with tumour response to TACE. Out of the two statistically 
significant variables, we found that the strongest predictive factor for better TACE response 
based on multiple linear regression analysis was the tumour size.  
Conclusions: Smaller tumor and higher tumour attenuation (measured in Hounsfield unit) 
were the significant predictive factors for better tumour response to TACE.  Location of the 
tumour showed no statistical significant association with better TACE response. 
  
 
 
x 
  
Keywords: Hepatocellular carcinoma, TACE, arterial phase CT scan, Hounsefield unit, 
drug eluting microparticles. 
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1.1 INTRODUCTION & LITERATURE REVIEW 
Hepatocellular carcinoma (HCC) is the commonest primary liver cancer. It accounts for 
6% of all cancers worldwide and the fifth commonest cancer in the world (1). The incidence 
of HCC increases with the increasing number of cases of Hepatitis B and Hepatitis C 
infection worldwide.  
In early stages cancer patient, the curative treatment is liver resection. A study by Zhang 
et al (2) mentioned that there is a 5-year survival rate of above 50% seen with liver resection 
of early stage cancer. Unfortunately, most of the patient presented with unresectable HCC 
due to late or advanced stages of disease. Thus, the treatments involve chemotherapy and/or 
radiotherapy. 
Transarterial chemoembolization (TACE) is one of the therapeutic alternative treatments 
offered for the unresectable hepatocellular carcinoma. The rationale for TACE is based on the 
dual supply of the liver which is by hepatic artery and portal vein (3). The main blood supply 
to the HCC is by the hepatic artery. Thus in TACE, the targeted feeding artery will be 
embolized causing necrosis of the HCC while the non effected hepatic parenchyma will not 
be affected due to preserved portal blood supply. Hepatocellular carcinoma is a hypervascular 
tumour and the direct intraarterial infusion of chemotherapeutic agents with or without 
hepatic artery occlusion has resulted in improved tumour response rates compared with 
systemic IV chemotherapy (4).  
There are several studies done previously to identify factors that affect response of HCC 
to transarterial chemoembolization. A study by Bryant M.K et al (5) demonstrated that 
peripherally located and small HCC tumours identified on pre-TACE computed tomography 
(CT) are more likely to experience complete or more than 90% tumour necrosis after TACE. 
Another study by Miraglia R et al (6) concluded that massive necrosis after TACE is more  
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common in the presence of tumour capsule, maximum diameter of the main lesion between 2 
and 6cm, Cancer of the Liver Italian Programme (CLIP) score less than 2 and absence of 
constitutional syndrome. This study also mentioned that the ability to predict which patients 
will response to TACE may be useful in clinical decision making process. Katyal et al (4) 
found that there is a statistically significant correlation between hypervascular tumour on 
arterial phase CT and response to TACE. A study done by Imai N et al (7) to determine 
characteristic of HCC tumour that are associated with lower recurrence rate after TACE. In 
the study, the author found that increase in tumour density on CT scan one week after TACE 
is associated with significantly lower local recurrence rate, thus better response to TACE. 
Extent of tumour necrosis by histopathological examination had also been used by Kwan et 
al. (8) to determine tumour response to TACE.  However, this study could not establish the 
significant correlation between imaging findings on pre-TACE CT and histopathological 
outcomes due to insufficient level of precision in CT imaging to differentiate between 
tumours to the same extent as in angiography (8). 
Owing to the fact that TACE procedure is an invasive and high cost procedure, therefore 
it would be beneficial if pre-TACE CT scan assessment is done to help in deciding on which 
tumour should be chemoembolized.  This study is to assess the predictive factors which are 
tumour attenuation, size of tumour and location of tumour in arterial phase CT with response 
of tumour to TACE procedure. 
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2.1  General objective:  
 
The aim of this study is to predict the hepatocellular carcinoma response (volume of residual 
viable tumour) to trans-arterial chemoembolization (TACE) by assessing the attenuation of 
tumour, size of tumour and site of tumour in hepatic arterial phase CT scan. 
 
 
2.2 Specific objectives: 
 
1. To evaluate demographic factors of patient with hepatocellular carcinoma who underwent 
TACE procedure. 
2. To identify the correlation between predictive factors (tumour attenuation, size and site of 
tumour) and response of tumor to TACE procedure. 
To determine which predictive factor which contributing more to better tumour response  
to TACE. 
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3.2 Title: Predictive Factors of Trans-arterial Chemoembolization Efficacy for 
Hepatocellular Carcinoma in Arterial Phase Computed Tomography Scan. 
 
3.2.1 Abstract 
Background: The aim of this study was (1) to evaluate demographic factors of patient with 
hepatocellular carcinoma who underwent TACE procedure (2) to identify the correlation 
between the predictive factors (tumour attenuation, size and location of tumour) and response 
of tumor (volume of residual viable tumour) to TACE procedure (3) to determine which 
predictive factor contribute more to better tumour response to TACE. 
Methodology: Patients diagnosed with Hepatocellular carcinoma in HUSM and Selayang 
Hospital who underwent TACE procedure using drug eluting microparticles as the embolic 
material were recruited. CT findings (pre and post TACE) of 144 tumours were analysed 
using several parameters (attenuation, size and site of tumour). Response of tumour to TACE 
was assessed based on reduction in tumour volume.  
Results: A total of 144 nodules of HCC were analyzed from pre- and post-TACE CT scan in 
arterial phase. Simple linear regression analysis revealed that tumour attenuation and size 
have significant association with the tumour response to TACE (P<0.001). There were no 
significant association found between the site of tumour [central or peripheral (p=0.453) and 
right lobe or left lobe (P=0.705)] with tumour response to TACE. Tumour size was the 
strongest predictive factor for better TACE response based on multiple linear regression 
analysis.  
Conclusions: Smaller tumour and higher tumour attenuation (measured in Hounsfield unit) 
were the significant predictive factors for better tumour response to TACE.  Location of the 
tumour showed no statistical significant association with better TACE response. 
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Keywords: Hepatocellular carcinoma, TACE, arterial phase CT scan, Hounsfield unit, drug 
eluting microparticles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
  
3.3 Introduction 
 Hepatocellular carcinoma (HCC) is the commonest primary liver cancer. It accounts 
for 6% of all cancers worldwide and the fifth commonest cancer in the world (1). The 
incidence of HCC increases with the increasing number of cases of Hepatitis B and Hepatitis 
C infection worldwide.  
In early stages cancer patient, the curative treatment is liver resection. A study by 
Zhang et al (2) mentioned that there is a 5-year survival rate of above 50% seen with liver 
resection of early stage cancer. Unfortunately, most of the patient presented with unresectable 
HCC due to late or advanced stages of disease. Thus, the treatments involve chemotherapy 
and/or radiotherapy. 
Transarterial chemoembolization (TACE) is one of the therapeutic alternative 
treatments offered for the unresectable hepatocellular carcinoma. The rationale for TACE is 
based on the dual supply of the liver which is by hepatic artery and portal vein (3). The main 
blood supply to the HCC is by the hepatic artery. Thus in TACE, the targeted feeding artery 
will be embolized causing necrosis of the HCC while the non-effected hepatic parenchyma 
will not be affected due to preserved portal blood supply. Hepatocellular carcinoma is a 
hypervascular tumour and the direct intraarterial infusion of chemotherapeutic agents with or 
without hepatic artery occlusion has resulted in improved tumour response rates compared 
with systemic IV chemotherapy (4).  
  There are several studies done previously to identify factors that affect response of 
HCC to transarterial chemoembolization. A study by Bryant M.K et al (5) demonstrated that 
peripherally located and small HCC tumours identified on pre-TACE computed tomography 
(CT) are more likely to experience complete or more than 90% tumour necrosis after TACE. 
Another study by Miraglia R et al (6) concluded that massive necrosis after TACE is more  
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common in the presence of tumour capsule, maximum diameter of the main lesion between 2 
and 6cm, Cancer of the Liver Italian Programme (CLIP) score less than 2 and absence of 
constitutional syndrome. This study also mentioned that the ability to predict which patients 
will response to TACE may be useful in clinical decision making process. Katyal et al (4) 
found that there is a statistically significant correlation between hypervascular tumour on 
arterial phase CT and response to TACE. A study done by Imai N et al (7) to determine 
characteristic of HCC tumour that are associated with lower recurrence rate after TACE. In 
the study, the author found that increase in tumour density on CT scan one week after TACE 
is associated with significantly lower local recurrence rate, thus better response to TACE. 
Extent of tumour necrosis by histopathological examination had also been used by Kwan et 
al. (8) to determine tumour response to TACE.  However, this study could not establish the 
significant correlation between imaging findings on pre-TACE CT and histopathological 
outcomes due to insufficient level of precision in CT imaging to differentiate between 
tumours to the same extent as in angiography (8). 
Owing to the fact that TACE procedure is an invasive and high cost procedure, therefore it 
would be beneficial if pre-TACE CT scan assessment is done to help in deciding on which 
tumour should be chemoembolized.  This study is to assess the predictive factors which are 
tumour attenuation, size of tumour and location of tumour in arterial phase CT with response 
of tumour to TACE procedure. 
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3.4 Methodology 
 
The aim of this study was to predict the hepatocellular carcinoma response to trans-
arterial chemoembolization (TACE). Patients diagnosed with Hepatocellular carcinoma from 
HUSM and Selayang Hospital who underwent TACE procedure using drug eluting 
microparticles as the embolic material were recruited from Picture Archive Communication 
System (PACS). The CT findings (pre and post TACE) of tumours were analysed using 
several parameters (Hounsfield unit, tumour size and tumour location). Tumour response to 
TACE was assessed base on reduction of the tumour volume.  
This study was a cross sectional study conducted at Hospital Universiti Sains 
Malaysia, Kelantan and Selayang Hospital. Data were collected from Picture Archive 
Communication System (PACS). The ethical approval was obtained from Human Research 
Ethics Committee of Universiti Sains Malaysia (JEPeM USM Code 
USMKK/PPP/JEPeM/15070260] which complies with the Declaration of Helsinki and from 
National Medical Research Register [(NMRR-16-1125-30175(IIR)]. 
The inclusion criteria were patients diagnosed with hepatocellular carcinoma 
subjected for TACE using drug eluting microparticles as the embolic material and had pre- 
and post- TACE CT scan. The exclusion criterion was TACE using oil-based radio-opaque 
contrast agent as the embolized material. 
By using Epicalc 2000 Software (using 95% confidence interval of ±5% precision to detect 
80.1% mean percentage reduction of viable tumour volume), a total of 144 tumour were 
recruited. This calculation was based on previous study by Bargellini et al (9). 
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3.4.1 CT Scan Technique and TACE technique: 
All patients underwent pre-TACE CT scan examinations using a Siemen CT scanner 
128 slices. Multiphases CT Liver performed using a 5mm thick sections and a 1mm to 5mm 
intersection gap. Each patient received 60 – 80mls of intravenous (IV) contrast media via a 
mechanical power injector. The IV contrast material was injected at the rates of from 2.5 to 
4.0 mL/sec. Arterial phase scan was acquired at 30 second post injection. Hepatocellular 
carcinoma was defined as mass within the liver parenchyma which demonstrates early arterial 
enhancement and contrast washout in portal venous phase.  Images were then transferred to 
PACS. 
TACE procedure was carried out through cannulation of coeliac artery, common 
hepatic artery and hepatic artery branches via femoral artery catheterization with a 5-French 
angiography catheter (eg:Yashiro catheter). Angiographic images were acquired during 
contrast injection. This was followed by cannulation of the arterial feeder with microcatheter 
through which the chemoembolic agent (drug eluting microparticle and 75mg Doxorubicin) 
was delivered. Images were then transferred to the PACS. 
CT scan was performed 6 weeks after the embolization to assess the tumour response. 
Data of pre- and post-TACE CT scan study in arterial phase were collected from PACS in 
HUSM and Selayang Hospital. 
 
3.4.2 Data Collection 
All the necessary data were retrieved from the PACS. The images were transferred 
into the Osirix system 3.2.1 version in an Apple MAC PRO PC with 2.66 GHz Dual Core 
Intel Xeon processor as the diagnostic viewing workstation. The monitor used for this work- 
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station was Apple Cinema HD Display (23” Flat Panel) with optimum resolution of 1920 x 
1200. Volumetric analysis was performed using the Osirix software by a single observer 
(researcher) who underwent a validation test by a well-trained Radiologist.  
The measurement of tumour volume in pre-TACE arterial phase CT images and the 
volume of residual viable tumour in post-TACE arterial phase CT images were taken using 
OSIRIX software ver.3.2.1. 
The independent variables were age, gender, Alpha-feto protein level, Hepatitis B 
status,  Hepatitis C status,  Child Pugh Score, tumour attenuation [mean lesion enhancement 
on CT in Hounsfield units (HU) was measured in the following manner. A circular region of 
interest (ROI) for each lesion was drawn to encompass the longest dimension of the tumour 
on contrast-enhanced CT imaging (7)], location [right lobe or left lobe; and peripheral or 
central location which was determined by labeling the tumour that was located at less or 
equal to 1cm from the periphery as peripherally located tumour and the rest were labelled as 
central] and size of tumour [in width and anteriorposterior diameter]. The dependent variable 
was tumour volume.  
To maintain patient’s privacy and confidentiality, the collected data were labelled as 
anonymous with numbers in the data collection sheet.  
 
3.4.3 Data Analysis 
 
Quantitative data were analysed using Microsoft® Office Excel and Statistical Product and 
Service Solutions (SPSS) for Windows, SPSS Inc.© (version 18, SPSS Inc., Chicago, 
IL,USA). Continuous variables are expressed as mean ± S.D or median (interquartile range, 
IQR) and categorical variables as percentages. The student’s and paired-sample t-tests were 
performed if normality was demonstrated by histogram. 
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Otherwise, non-parametric tests (Mann-Whitney U or Wilcoxon signed rank tests) 
were used. Chi-square test was used to compare the categorical variables. All statistical tests 
were considered significant when the two-sided p value was < 0.05. Simple linear regression 
and multiple linear regression analysis were used to analyze the predictive factors and tumour 
response to TACE. 
3.5 Results 
3.5.1  Demographic data. 
  A total of 144 nodules were chosen from selected patients. The mean age of the study 
subjects were 61±7 years-old (SD: 7.1) (Table 1). Majority of the study subjects were male 
86.1% while female comprised of 13.9 %. Thirteen point nine percent had hepatitis B and 
70.8% had hepatitis C. Mean AFP level of study subjects were 1459.19±3577.83 µg/L. The 
Child Pugh score of the study subjects were of A (66%) and B (34%).  
Table 2 shows the analysis of the subject demographic data according to the two 
different types of infection. For disease caused by Hepatitis B virus, the mean age of the 
study subjects was 61±7 years-old with minimum and maximum ages of 45 and 79, 
respectively. For disease caused by Hepatitis C virus, the mean age of the study subjects was 
61±7 years-old with minimum and maximum ages of 41 and 79, respectively. There was no 
significant difference between the mean ages of the two groups. Subjects with Hepatitis B 
virus infection comprised 11.9% female and 88.1% male; while that of Hepatitis C virus 
infection consisted of 14.7% female and 85.3% male. There was no significant difference in 
the distribution of gender between these two study groups. There were also no significant 
difference between ALP levels for subjects with Hepatitis B (1185.69±2581.46 µg/L) and 
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Hepatitis C (1571.81±3921.10 µg/L) infections. Similarly, no significant difference found 
between distribution of Child Pugh score of subjects with Hepatitis B and Hepatitis C (Table 
2). 
3.5.2 Correlation between predictive factors (tumour attenuation, size and site of 
tumour) and tumour response to TACE procedure. 
 
3.5.2.1 Correlation between tumour attenuation and size and tumour response to TACE 
(Table 3) 
In Pearson correlation analysis on association between tumour attenuation and tumour size 
and response of tumour to TACE, HU revealed strong positive correlation (r=0.740, p<0.05) 
with the treatment response; while tumour size of AP and width showed moderate negative 
correlations (i.e. r=-0.405, p<0.05; r=-0.491, p<0.05, respectively) with treatment responses. 
 
3.5.2.2 Comparison response of tumour to TACE attributed to site of tumour 
There was no significant difference in treatment responses of subjects with different site of 
tumours. (Table 4) 
 
3.5.3 Simple linear regression analysis on predictive factors associated with response 
of tumour to TACE (Table 5) 
Predictive factors contribute to better tumour response to TACE were analysed by simple 
linear regression. Among the analysed predicting factors i.e. HU, AP, width, intra-lobe 
location and site of liver lobe, only the first three variables (HU, AP, width) revealed 
significant association with the tumour response to TACE. For HU, an increase of each HU 
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was associated with an increase of 0.682 treatment response percentage. For AP, an increase 
of each AP unit was associated with a decrease of 3.852 treatment response percentage. For 
width, an increased of each width was associated with a decreased of 5.532 treatment 
response percentage. There was no significant association found between the tumour location 
and tumour response to TACE. 
 
3.5.4 Multiple linear regression analysis on predictive factors associated with response 
of tumor to TACE (Table 6) 
Predictive factors significantly associated with tumour response to treatment were then 
analyzed by multiple linear regression. After adjustment with the tumour size, i.e. width, an 
increase of each Hounsfield unit was associated with an increase of 0.596 treatment response 
percentage. On the other hand, an increase of each WT unit was associated with a decrease of 
2.707 treatment response percentage. 
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3.6 Discussion 
 
 Transarterial chemoembolization (TACE) is a therapeutic alternative treatments 
offered for the unresectable hepatocellular carcinoma.  The aim of TACE is to occlude the 
blood supply to the tumour as well as delivering chemotherapy drugs to the tumour. 
This study focused on the use of arterial phase CT scan to assess the enhancement, 
size and location of hepatocellular carcinoma to predict which patients would obtain the most 
benefit from transarterial chemoembolization. We assessed the TACE response by measuring 
percentage of tumour reduction by comparing the pre and post TACE CT scan in arterial 
phase.  
 Previous study by Yamashita et al. (10) found that hypovascular tumours showed less 
response to transarterial chemoembolization (TACE). This is supported by another study 
done by Katyal et al. (4) which concluded that hypervascular tumour shows better response to 
TACE. From our study, two out of the three variables that were analysed showed statistically 
significant findings. The first variable that was analysed was the Hounsfield unit (HU) of the 
lesion in the arterial phase CT of liver. We found that lesions with higher enhancement 
(increasing HU) were showing significantly better response to transarterial 
chemoembolization. Generally, HCC receives its blood supply from hepatic artery. Increase 
in attenuation of the tumor signifies hypervascularity of the lesion.  Findings in our study 
support the proposal that tumor with more enhancement has better blood supply hence more 
likely to take up embolic material and develop necroses. 
 The second variable that was assessed was the size of tumour in the AP 
(Anterioposterior) diameter and the width. Based on this study, it was shown that size of the 
lesion affects the outcome of TACE. We found that lesions with smaller size (both in AP 
diameter and width) showed better response to TACE. This is likely due to lesser area to  
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tackle during TACE procedure and ample amount of chemo drugs concentrated within the  
smaller size tumour and hence better response.  This finding is similar to previous study by 
Bryant MK et al. (5) in which they found that smaller tumour size were significantly 
associated with favourable response to TACE  whereby complete or more than 90% tumor 
necrosis was achieved. 
 The third variable which was location of the tumour showed no significant association 
with TACE response. Lesions location either in the right lobe, left lobe, at the center or 
periphery of liver proved no statistically significant findings. These findings were not in line 
with the previous study done by Bryant MK et al. (5) in which they found that peripherally 
located tumour was more likely to experience more tumour necrosis after TACE. This could 
be explained by slight modification technique done in our study whereby we classified 
tumour that was located at less or equal to 1cm from periphery as peripherally located tumour 
and the rest were labelled as central. However, the previous study done by Bryant MK et al. 
(5) labelled tumour as peripheral if located greater than 4cm from the portal vein bifurcation 
and centrally located tumour if within 4cm of the portal vein bifurcation. There was no 
previous study done comparing right and left lobe of liver as tumour location.  
 Out of the two statistically significant variables, we found that the strongest predictive 
factor for better TACE response based on multiple linear regression analysis was the tumour 
size. Our study demonstrated that with increase of each Hounsfield unit associated with an 
increased of 0.596 treatment response percentage. On the other hand, an increase of size 
(width) was associated with a decreased of 2.707 treatment response percentage. 
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This study is clinically important because tumour size and Hounsfield unit are easily obtained 
from CT imaging. Selection of tumour which is small and shows better enhancement as 
compared to bigger tumour can be decided from CT scan itself.  
In conclusion, we demonstrate a smaller tumour size and higher Hounsfield unit as the 
significant predictive factors for better tumour response to TACE. This might help in the 
patient’s management and selection for treatment method or procedure.  
 
 
3.7 Conclusion: 
Smaller tumor size and higher Hounsfield unit are the significant predictive factors for 
better tumour response to TACE.  Location of the tumour shows no statistical significant 
association with better TACE response.  
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3.9 TABLES AND FIGURES 
Table 1: Demographic data (n=144) 
Variable Value 
Age, year  
 Mean 61.2 
 SD 7.1 
 Min 41 
 Max 79 
Gender, n (%)  
 Female 20 (13.9) 
 Male 124 (86.1) 
  
Hepatitis status, n (%)  
 B 42 (29.2) 
 C 102 (70.8) 
  
Alpha feto protein level (µg/L)  
 Normal (<7), n (%) - 
 Abnormal (>7), n (%) 144 (100) 
  
 Abnormal (7-500), n (%) 77 (53%) 
 Suggestive of hepatoma (>500), n (%) 67 (47%) 
  
Child Pugh Score, n (%)  
 A 95 (66.0) 
 B 49 (34.0) 
 C - 
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Table 2: Demographic data of study subjects according to different types of hepatitis 
infection 
Variable 
Types of Infection 
                   P value 
                Hepatitis B                       Hepatitis C 
    
Age   0.965a 
 Mean 61.2 61.2  
 SD 6.7 7.3  
 Min 45 41  
 Max 79 79  
    
Gender, n (%)   0.659b 
 Female 5 (11.9) 15 (14.7)  
 Male 37 (88.1) 87 (85.3)  
    
Alpha feto protein level (µg/L) 1185.69 (2581.46) 1571.81 (3921.10) 0.558a 
 Normal (<7) , n (%) - -  
 Abnormal (>7) , n (%) 42 (100) 102 (100)  
    
 Abnormal (7-500), n (%) 20 (48) 57 (56) 0.366b 
 Suggestive of hepatoma 
 (>500) , n (%) 
22 (52) 45 (44)  
    
Child Pugh Score, n (%)   0.357 b 
 A 30 (71.4) 65 (63.7)  
 B 12 (28.6) 37 (36.3)  
 C - -  
    
Note: aindependent t-test, bchi-square test for homogeneity 
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